Vanda Pharmaceuticals Inc (VNDA)
5.48
-0.10
(-1.79%)
USD |
NASDAQ |
May 17, 16:00
5.485
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Accounts Payable (Quarterly): 4.342M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.342M |
December 31, 2023 | 7.145M |
September 30, 2023 | 3.488M |
June 30, 2023 | 2.17M |
March 31, 2023 | 3.80M |
December 31, 2022 | 12.69M |
September 30, 2022 | 13.43M |
June 30, 2022 | 16.41M |
March 31, 2022 | 14.33M |
December 31, 2021 | 0.925M |
September 30, 2021 | 1.299M |
June 30, 2021 | 2.117M |
March 31, 2021 | |
December 31, 2020 | 1.049M |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | 1.631M |
March 31, 2015 | 1.49M |
December 31, 2014 | |
September 30, 2014 | 0.547M |
June 30, 2014 | 0.248M |
March 31, 2014 | 0.953M |
December 31, 2013 | 0.661M |
September 30, 2013 | 0.369M |
June 30, 2013 | 1.167M |
March 31, 2013 | 1.113M |
December 31, 2012 | 0.287M |
September 30, 2012 | 1.09M |
June 30, 2012 | 1.689M |
March 31, 2012 | 0.78M |
December 31, 2011 | 0.996M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.925M
Minimum
Dec 2021
16.41M
Maximum
Jun 2022
6.400M
Average
3.80M
Median
Mar 2023
Accounts Payable (Quarterly) Benchmarks
ADMA Biologics Inc | 17.19M |
INVO Bioscience Inc | 2.330M |
Nektar Therapeutics | 8.757M |
Ligand Pharmaceuticals Inc | 1.893M |
Invivyd Inc | 1.168M |